Back
Day Range
$4.25
$4.60
52-Week Range
$2.71
$5.10
Volume
7,584,933
50D / 200D Avg
$4.34
/
$4.10
Prev Close
$4.24
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -25.4 | 0.4 |
| P/B | 11.1 | 2.9 |
| ROE % | -38.5 | 3.7 |
| Net Margin % | -237.9 | 3.8 |
| Rev Growth 5Y % | 6.4 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 6.40% annually over 5 years — modest growth
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -39.64M
PEG of 0.50 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 121.81%
Capital efficient — spends only 0.00% of revenue on capex
Growth
Revenue Growth (5Y)
6.40%
Revenue (1Y)128.21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-38.52%
ROIC-37.01%
Net Margin-237.88%
Op. Margin-270.96%
Safety
Debt / Equity
0.01
Current Ratio15.73
Interest Coverage393.40
Valuation
P/E Ratio
-25.37
P/B Ratio11.10
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 128.21% | Revenue Growth (3Y) | -11.89% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6.40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.08M | Net Income (TTM) | -33.50M |
| ROE | -38.52% | ROA | -35.41% |
| Gross Margin | 0.00% | Operating Margin | -270.96% |
| Net Margin | -237.88% | Free Cash Flow (TTM) | -39.64M |
| ROIC | -37.01% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 15.73 |
| Interest Coverage | 393.40 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -25.37 | P/B Ratio | 11.10 |
| P/S Ratio | 60.36 | PEG Ratio | 0.50 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 850.07M | Enterprise Value | 832.81M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.08M | 6.17M | 18.14M | 39.02M | 10.99M |
| Net Income | -33.50M | -69.92M | -72.85M | -69.46M | -76.25M |
| EPS (Diluted) | -0.17 | -0.38 | -0.44 | -0.46 | -0.73 |
| Gross Profit | 0.0 | 6.17M | 18.14M | 39.02M | 10.99M |
| Operating Income | -38.16M | -76.32M | -78.10M | -65.46M | -73.52M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94.62M | 131.71M | 144.40M | 195.42M | 204.49M |
| Total Liabilities | 18.04M | 34.34M | 38.38M | 58.57M | 35.05M |
| Shareholders' Equity | 76.58M | 97.37M | 106.02M | 136.85M | 169.44M |
| Total Debt | 746,000.0 | 1.29M | 8.72M | 12.55M | 18.91M |
| Cash & Equivalents | 18.01M | 36.33M | 26.29M | 30.78M | 109.28M |
| Current Assets | 94.46M | 127.32M | 132.03M | 151.14M | 160.66M |
| Current Liabilities | 6.01M | 15.62M | 22.49M | 32.86M | 11.22M |